Skip to main navigation
Skip to search
Skip to main content
Penn State Home
Help & FAQ
Home
Researchers
Research output
Research units
Equipment
Grants & Projects
Prizes
Activities
Search by expertise, name or affiliation
Targeting hexokinase 2 in castration-resistant prostate cancer
Yibin Deng,
Junxuan Lu
Penn State Cancer Institute
Cancer Institute, Next-Generation Therapies
Center for Cannabis and Natural Product Pharmaceuticals (CCNPP)
Penn State Neuroscience Institute
Department of Neuroscience and Experimental Therapeutics
Research output
:
Contribution to journal
›
Comment/debate
›
peer-review
21
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Targeting hexokinase 2 in castration-resistant prostate cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Aerobic Glycolysis
33%
Cancer Cells
33%
Cancer Hallmarks
33%
Castration-resistant Prostate Cancer
100%
Hexokinase
100%
Prostate Cancer Patients
33%
Pten
33%
PTEN mutation
33%
Therapeutic Target
33%
TP53 mutation
33%
Warburg Effect
66%
Pharmacology, Toxicology and Pharmaceutical Science
Castration Resistant Prostate Cancer
100%
Hexokinase
100%
Malignant Neoplasm
33%
Prostate Cancer
33%
Protein P53
66%
Biochemistry, Genetics and Molecular Biology
Aerobic Glycolysis
33%
Cancer Cell
33%
Hexokinase
100%
P53
66%
Warburg Effect
66%
Immunology and Microbiology
Aerobic Glycolysis
50%